Investigate / HSIC
Understand HENRY SCHEIN INC
Can the company's broad single-source supply model keep customers and manage supplier dependence as the market consolidates?
Snapshot reviewed 2026-10-03. Source published 2026-08-04. No account needed.
AI-assisted synthesis of selected public filings, checked against the cited excerpts. Not a complete analysis.
This is a research starting point, not a buy/sell recommendation or a current valuation. New developments after these sources are not incorporated automatically.
Your research workspace / HSIC
Ask better questions. Keep the evidence.
Explore the available sources for HENRY SCHEIN INC, then keep what deserves another look.
01 Investor activity
Who reports owning HSIC?
4 tracked reported owners. Disclosures are delayed and may describe different quarters—not live holdings or stated motives.
02 Business evidence
Reported evidence
What does the company do?
Henry Schein distributes products and services to dental and medical markets, manufactures specialty health-care products and develops practice-management software.
Latticework interpretation
What could support the case?
If distribution infrastructure and broad offerings continue to support accurate fulfillment, Henry Schein could remain a valued single source of supply; management’s belief is not proof of a moat.
Latticework interpretation
What could break the case?
If supply interruptions cannot be resolved promptly, sales, operations and customer relationships could be harmed.
03 Questions to investigate
Open saved takeaways →Read the full company brief
1. Understand the business
Henry Schein distributes products and services to dental and medical markets, manufactures specialty health-care products and develops practice-management software.
Source: Annual filing · business description ↗2. What the reported results show
Latest source: 10-Q, reporting period ended 2026-06-27. Selected reported US-GAAP/USD comparisons. The period and basis of each measure are shown separately; year-to-date cash flow is not a quarterly figure. Missing comparisons are collection gaps, not evidence that a company has no revenue or earnings.
| Measure | Current | Prior year |
|---|---|---|
| Revenue from customer contracts ↗Quarter: 2026-03-29–2026-06-27; prior 2025-03-30–2025-06-28Both values reported in the current filing. Excludes assessed tax; this concept may exclude other company revenue. | $3,458m | $3,240m |
| Operating income ↗Quarter: 2026-03-29–2026-06-27; prior 2025-03-30–2025-06-28Both values reported in the current filing. | $171m | $151m |
| Net income ↗Quarter: 2026-03-29–2026-06-27; prior 2025-03-30–2025-06-28Both values reported in the current filing. | $94m | $86m |
| Operating cash flow ↗Six months (year to date): 2025-12-28–2026-06-27; prior 2024-12-29–2025-06-28Both values reported in the current filing. Operating cash flow is not free cash flow or a standalone solvency assessment; inspect the full statement. | $145m | $157m |
3. The investment debate
Latticework interpretation of the reported results—not the stated motives of any investor.
What could support the case
If distribution infrastructure and broad offerings continue to support accurate fulfillment, Henry Schein could remain a valued single source of supply; management’s belief is not proof of a moat.
Supporting filing ↗The strongest caution
If supply interruptions cannot be resolved promptly, sales, operations and customer relationships could be harmed.
Caution evidence ↗An interesting business is not necessarily an attractive investment at today's price. Price, dilution, financing terms and a valuation range still need investigation.
Inspect the evidence behind both sides ↗4. Three questions worth investigating
Use these to guide your research, not as conclusions that have already been proved.
How concentrated and replaceable are key supply sources?
Starting evidence: Third-party suppliers provide a significant volume of products, and key suppliers collectively supply a significant portion.
Investigate next: Review supplier contract terms, rebate arrangements and any disclosed supply interruptions or recalls affecting distribution or specialty manufacturing.
Read the supporting filing ↗Is the growth plan producing measurable progress?
Starting evidence: If the strategic plan is not implemented effectively, returns on growth investments may fall short.
Investigate next: Compare management's stated plan priorities with segment results, acquisition integration disclosures and any restructuring outcomes in later filings.
Read the supporting filing ↗How might customer consolidation affect terms?
Starting evidence: Collective buying groups emphasize competitive prices and specialized management-information support.
Investigate next: Look for disclosure on customer concentration, group purchasing arrangements, pricing pressure and competition from online commerce sites.
Read the supporting filing ↗5. Decide what to do next
Worth another look? Save this company and return to the evidence. Writing a private view is optional. You do not need to decide whether to invest today.
Save is on this device. Recording a private view requires sign-in and an explicit save. Neither action subscribes you to email or automatically evaluates your thesis.